Necmettin Erbakan University is a public university in Konya, Turkey.

During the past decade, Necmettin Erbakan University Meram Medical Faculty conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Necmettin Erbakan University Meram Medical Faculty" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Celgene" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored and "Gazi University" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Necmettin Erbakan University Meram Medical Faculty" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator, "European Society for Emergency Medicine (EUSEM) Research Network" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Necmettin Erbakan University Meram Medical Faculty" are "Arthritis, Psoriatic" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Breast Cancer" (1 trials), "Early Warning Score" (1 trials) and "Emergencies" (1 trials). Many other conditions were trialed in "Necmettin Erbakan University Meram Medical Faculty" in a lesser frequency.

Most popular intervention types in "Necmettin Erbakan University Meram Medical Faculty" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Guselkumab" (2 trials), "Amivantamab" (1 trials), "Archival Tumor Tissue Sample" (1 trials) and "Avelumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Necmettin Erbakan University Meram Medical Faculty" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Necmettin Erbakan University Meram Medical Faculty". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Necmettin Erbakan University Meram Medical Faculty, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Necmettin Erbakan University Meram Medical Faculty, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".